Is it safe to continue Tezspire after hives and FEV1 70 %?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

My 14-year-old daughter started Tezspire injections three months ago for severe asthma. Before this, her asthma was poorly controlled despite high-dose Advair, Singulair, and frequent Prednisone bursts. She had two hospitalizations earlier this year.

Her pulmonologist noted an eosinophil count of 890 and a FeNO of 51 ppb. Since starting Tezspire, her asthma attacks have decreased, but she still needs her albuterol inhaler three to four times per week. After her most recent injection, she developed widespread hives and had difficulty breathing within an hour. The on-call physician said it was not anaphylaxis, but we are concerned about continuing treatment.

While her nighttime symptoms have improved, she still cannot tolerate physical activity like soccer without wheezing. Her most recent PFTs show an FEV1 of only 72 percent predicted.

How long should we continue Tezspire before determining if it is effective? Are these side effects typical, and should we be worried about the persistent lung function issues? Please help.

Thank you.

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

Tezspire (Tezepelumab) helps reduce asthma (a chronic condition that affects the airways in the lungs) inflammation, and it is encouraging that your daughter’s symptoms have improved. However, needing Albuterol three to four times a week shows her asthma is not fully controlled yet. It may take more time to see the full benefit, but if there is little change in the next few months, other treatments may need to be considered.

The hives (raised, itchy, red or skin-colored welts on the skin) and breathing difficulty after her last injection are concerning. While it may not have been a full anaphylaxis (severe allergic reaction), these symptoms are not typical and should be taken seriously. It is important to speak with her pulmonologist about whether Tezspire is still the right option.

An FEV1 (forced expiratory volume in one second) of 72 percent predicted points to moderate airflow limitation. Although Tezspire is helping, it might not be enough to fully control her asthma, especially since she still has trouble with physical activity like soccer.

Continue monitoring her symptoms closely, report all side effects to her doctor, and consider discussing alternative therapies if improvement stalls or side effects persist. Her treatment plan might need adjusting for better control and safety.

I hope this helps.

Kindly revert so I can assist you further.

Thank you.

Medically reviewed byiCliniq medical review team

Published At July 24, 2025
Reviewed AtJuly 28, 2025

Same symptoms don't mean you have the same problem. Consult a doctor now!

Listen to related tracks in our music library

Read answers about:

tezepelumabasthma

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy